The honest numbers first
SURMOUNT-4 is the closest thing to a controlled answer. After 36 weeks on tirzepatide, half the participants were switched to placebo without knowing it. Over the next year the average person in that group regained most of what they had lost. That is the number the “you will just gain it all back” comments are built on, and it is real. But the same trial contains the number nobody quotes: about one in six of the people cut off cold held on to at least 80% of their loss anyway, with no plan, no coaching, and no warning. Average is not destiny. The question is not whether keeping it off is possible; it is what moves you out of the average.
Know the timeline you are walking into
Tirzepatide clears faster than semaglutide: a half-life of about 5 days means the drug is largely gone within three to four weeks of the last shot. In practice the transition has a shape. Week 1: deceptively normal, half your steady level is still circulating, and this calm window is the free setup time. Weeks 2 to 4: appetite returns, and the scale may jump 3 to 6 lbs of water and glycogen that panicky people misread as instant fat regain. Weeks 3 to 10: the overshoot window, when hunger can run above its old baseline while your portion instincts are still calibrated to a medicated appetite. The washout calculator draws your exact curve from your last dose date, and stopping Zepbound or Mounjaro covers the week-by-week in detail.
What the keepers actually do
- A protein floor, locked in before hunger returns. Roughly 1.6 g per kg of goal weight, front-loaded at breakfast. This is the single biggest softener of the rebound, and the calm first week is when to build the habit. The protein calculator gives your number.
- Two or three strength sessions a week. Muscle is the engine that sets your maintenance burn, and it is the part of a fast loss most worth defending. Nothing fancy survives contact with real life; two focused sessions do.
- Fiber at 25 to 30 grams. The maintenance communities repeat it more than any supplement: protein alone did not quiet returning appetite until fiber came up too.
- A weekly average against a chosen line. Daily weights lie; weekly averages trend. The keepers pick a ceiling number in advance and treat 3 lbs of drift as a trigger for action, not a moral event. That single habit converts regain from a slow surprise into an early decision.
- A pre-decided response to the loud nights. Food noise returning is biology, not backsliding. The food noise comeback has a timeline and a protocol; meeting it with a plan is what separates a loud week from an undone year.
Notice what is not on the list: heroic cardio, 1,200-calorie resets, and cutting out food groups. The people who keep large losses off eat more than you would guess, at a maintenance level their new body actually supports. The maintenance calorie calculator includes the metabolic adaptation step that explains why the number is lower than the generic calculators say, and why pretending otherwise ends in the rebound.
If you have a choice about how you stop
Plenty of people do not; insurance decides for them, and that abrupt version is covered honestly in stopping a GLP-1 cold turkey. If you and your prescriber can choose, a step-down spreads the appetite transition across months instead of six weeks, and holding a low rung indefinitely is also a legitimate landing spot, covered in the Zepbound maintenance dose guide. The Ozempic version of this playbook lives at keeping the weight off after Ozempic if that is your medication.
Frequently asked questions
Has anyone actually kept the weight off after stopping Zepbound or Mounjaro?
Yes. In SURMOUNT-4, people switched from tirzepatide to placebo regained most of their loss on average within a year, but about one in six still held on to at least 80% of what they had lost, with no plan, no support, and no idea they had been switched. That is the floor, not the ceiling: the maintainers in the community pair a protein floor, strength training and a watched weekly trend, and they are the ones writing the success posts.
How fast does weight come back after stopping Zepbound?
Not instantly. Tirzepatide has a half-life of about 5 days, so the first week feels normal. Appetite typically returns in earnest during weeks 2 to 4, and the highest-risk stretch is roughly weeks 3 through 10, when hunger can overshoot its old baseline while your habits are still calibrated to a suppressed appetite. Fat regain requires a sustained calorie surplus over weeks; the early scale jump is mostly water.
Why did I gain 3 to 6 pounds the first two weeks off?
Water and glycogen, overwhelmingly. As the medication clears and eating patterns shift, your body restocks glycogen and the water bound to it, and the scale jumps before any meaningful fat change is possible. Expecting this jump is protective: the people who panic at it are the ones who declare failure in week two and stop defending a loss they had not actually lost.
Do I need to taper off Zepbound instead of stopping cold turkey?
There is no trial proving taper beats abrupt stopping for keeping weight off, and no dangerous withdrawal either way. What a taper changes is the height of the drop: stepping down spreads the appetite transition over months instead of concentrating it into one 3-to-6-week window. Many prescribers favor it for exactly that reason. Either way the dose plan belongs with your prescriber, and our cold turkey guide covers the abrupt version honestly.
What should I focus on in the first month off Zepbound?
Three things, in order: lock a protein floor before hunger returns (the calm first week or two is the setup window), get a weekly weigh-in trend running with a line you do not want to cross, and put two strength sessions on the calendar. Hunger arriving is normal biology, not relapse. The plan exists so that when it arrives, it hits structure instead of improvisation.
If the weight starts coming back, can I just go back on?
Often yes, and catching drift early is what keeps that option cheap. A restart conversation at 5 lbs up is routine; at 25 lbs up it may involve new insurance authorization, a new titration from the bottom, and months of lost ground. This is the strongest practical argument for watching a weekly average against a line: it converts regain from a surprise into a decision point.
Sources
- SURMOUNT-4: Aronne LJ et al. Continued treatment with tirzepatide for maintenance of weight reduction. JAMA, 2024.
- SURMOUNT-1: Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med, 2022.
- Zepbound prescribing information: Zepbound (tirzepatide) full prescribing information, via DailyMed (NIH).
- Morton et al. protein meta-analysis: Morton RW et al. Systematic review, meta-analysis and meta-regression of protein supplementation and resistance training (n=1,863). Br J Sports Med, 2018.
- Biggest Loser 6-year follow-up: Fothergill E et al. Persistent metabolic adaptation 6 years after "The Biggest Loser" competition. Obesity, 2016.
- Community reports compiled from r/Zepbound_Maintenance and r/MounjaroMaintenance (2026): protein, fiber, strength training and weekly trend-watching are the most repeated maintainer behaviors.
Linked citations open on PubMed or DailyMed, both run by the US National Institutes of Health. Where a claim on this page comes from reporting or clinical commentary we could not resolve to a stable public record, it is listed above without a link rather than pointed at an approximation.